Literature DB >> 18415236

[Intractable cancer pain as a reason for referral : Analysis of pain etiology and previous drug treatment.].

S Grond1, D Zech, H Dahlmann, S A Schug, B Stobbe, K A Lehmann.   

Abstract

Many studies have demonstrated that cancer pain can be relieved in most cases by suitable analgesic medication. Patients with a diagnosis of "intractable cancer pain", however, are referred to our pain clinic nearly every day. A retrospective study of 1140 patients was therefore performed to evaluate the pain mechanisms and whether analgesic pretreatment had been adequate. Half of the patients (53%) were suffering from pain at more than one site. The most frequent locations were the back (36% of the patients), abdomen (30%), and the thoracic (22%) region. The main pain etiologies were compression or infiltration of pain-sensitive structures by the tumor (84% of the patients), and less frequently oncological treatment (18%), debilitating disease (10%), or causes unrelated to tumor or therapy (9%). Pain could be classified with almost equal frequency as neuropathic, visceral, soft tissue-related, or bone-related. Upon admission to our pain clinic, most patients (86%) indicated pain of severe intensity. The principal causes for the inadequacy of the analgesic pretreatment were: failure to prescribe analgesics (10% of the patients), irregular intake schedule or prolonged intervals between applications (66%), underdosage of nonopioid analgesics (27%) or opioids (42%), and withholding of nonopioid analgesics (30%), strong opioids (14%), or co-analgesic drugs (17%), although their prescription was indicated. The severe pain was thus caused in many patients by simple mistakes in the prescription of analgesics. Terms like "intractable" should be used with caution when referring to cancer pain because they are often unreflected and can make patients and physicians feel helpless or insecure.

Entities:  

Year:  1990        PMID: 18415236     DOI: 10.1007/BF02527903

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  31 in total

1.  [Long-term therapy of cancer pain. A controlled study on buprenorphine].

Authors:  M Zenz; S Piepenbrock; M Tryba; M Glocke; M Everlien; W Klauke
Journal:  Dtsch Med Wochenschr       Date:  1985-03-22       Impact factor: 0.628

2.  The measurement of clinical pain intensity: a comparison of six methods.

Authors:  Mark P Jensen; Paul Karoly; Sanford Braver
Journal:  Pain       Date:  1986-10       Impact factor: 6.961

3.  Patterns of narcotic drug use in a cancer pain clinic.

Authors:  R M Kanner; K M Foley
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

4.  Psychopharmacologic applications to cancer. An overview.

Authors:  L R Derogatis
Journal:  Cancer       Date:  1982-11-01       Impact factor: 6.860

Review 5.  The treatment of cancer pain.

Authors:  K M Foley
Journal:  N Engl J Med       Date:  1985-07-11       Impact factor: 91.245

6.  Pain characteristics and treatment in an outpatient cancer population.

Authors:  J Peteet; V Tay; G Cohen; J MacIntyre
Journal:  Cancer       Date:  1986-03-15       Impact factor: 6.860

7.  [Cancer pain.].

Authors:  P Porges
Journal:  Schmerz       Date:  1988-06       Impact factor: 1.107

8.  Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain.

Authors:  S Arnér; B A Meyerson
Journal:  Pain       Date:  1988-04       Impact factor: 6.961

9.  Pain in far-advanced cancer.

Authors:  Robert G Twycross; Sarah Fairfield
Journal:  Pain       Date:  1982-11       Impact factor: 6.961

10.  Chronic use of opioid analgesics in non-malignant pain: report of 38 cases.

Authors:  Russell K Portenoy; Kathleen M Foley
Journal:  Pain       Date:  1986-05       Impact factor: 6.961

View more
  13 in total

Review 1.  [Symptom and complaint validation of chronic pain in social medical evaluation. Part II: Analysis levels and assessment recommendations].

Authors:  R Dohrenbusch
Journal:  Schmerz       Date:  2009-06       Impact factor: 1.107

2.  [Not Available].

Authors:  D Zech
Journal:  Schmerz       Date:  1991-06       Impact factor: 1.107

3.  [AIDS and pain management-a survey of German AIDS and pain management units.].

Authors:  D Zech; L Radbruch; S Grond; W Heise
Journal:  Schmerz       Date:  1994-06       Impact factor: 1.107

4.  [Opioids in "non-malignant" pain-results of long-term treatment in patients with rheumatic disease.].

Authors:  J Sorge; B Steffmann; C Lehmkuhl; I Pichlmayr
Journal:  Schmerz       Date:  1991-06       Impact factor: 1.107

5.  [Prevalence and characteristics of neuropathic pain in malignant disease.].

Authors:  S Grond; D Zech; T Meuser; L Radbruch; M Kasper; K A Lehmann
Journal:  Schmerz       Date:  1992-06       Impact factor: 1.107

6.  [Prescription of opiates. Analysis of outpatient care of pain patients insured with the AOK.].

Authors:  A Willweber-Strumpf; M Zenz; M Strumpf
Journal:  Schmerz       Date:  1992-12       Impact factor: 1.107

7.  [Slow-release morphine liquid suspension for the therapy of cancer pain and non-cancer pain-A pilot study.].

Authors:  M Strumpf; B Donner; M Zenz
Journal:  Schmerz       Date:  1995-05       Impact factor: 1.107

8.  [Prescription of strong opioids by general practitioners in Germany.].

Authors:  G Lindena; T Zenz
Journal:  Schmerz       Date:  1994-12       Impact factor: 1.107

9.  [Patient-controlled analgesia with subcutaneous opoids for out-patients with severe tumour pain.].

Authors:  H Goeke; M Herbst
Journal:  Schmerz       Date:  1993-03       Impact factor: 1.107

10.  [Patient-controlled analgesia in outpatients with severe cancer pain.].

Authors:  M Herbst; H Goeke
Journal:  Schmerz       Date:  1995-03       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.